[1]
D. G. Krishnan and A. V. Keloth, “Formoterol versus montelukast as add on therapy to low dose budesonide in persistent asthma: effect on lung function”, Int J Basic Clin Pharmacol, vol. 7, no. 6, pp. 1186–1190, May 2018.